Switzerland · Delayed Price · Currency is CHF Medacta Group Statistics
Total Valuation
Medacta Group has a market cap or net worth of CHF 2.26 billion. The enterprise value is 2.52 billion.
| Market Cap | 2.26B |
| Enterprise Value | 2.52B |
Important Dates
The last earnings date was Wednesday, September 9, 2026.
| Earnings Date | Sep 9, 2026 |
| Ex-Dividend Date | May 7, 2026 |
Share Statistics
Medacta Group has 19.95 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 19.95M |
| Shares Outstanding | 19.95M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 69.75% |
| Owned by Institutions (%) | 7.73% |
| Float | 6.03M |
Valuation Ratios
The trailing PE ratio is 31.74 and the forward PE ratio is 23.30. Medacta Group's PEG ratio is 1.78.
| PE Ratio | 31.74 |
| Forward PE | 23.30 |
| PS Ratio | 3.46 |
| PB Ratio | 5.07 |
| P/TBV Ratio | 5.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 18.10 |
| PEG Ratio | 1.78 |
Enterprise Valuation
| EV / Earnings | 35.39 |
| EV / Sales | 3.86 |
| EV / EBITDA | 15.20 |
| EV / EBIT | 25.44 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.66.
| Current Ratio | 2.10 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | -181.22 |
| Interest Coverage | 18.70 |
Financial Efficiency
Return on equity (ROE) is 17.03% and return on invested capital (ROIC) is 11.04%.
| Return on Equity (ROE) | 17.03% |
| Return on Assets (ROA) | 7.19% |
| Return on Invested Capital (ROIC) | 11.04% |
| Return on Capital Employed (ROCE) | 13.93% |
| Weighted Average Cost of Capital (WACC) | 8.83% |
| Revenue Per Employee | 287,473 |
| Profits Per Employee | 31,386 |
| Employee Count | 2,273 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 0.86 |
Taxes
In the past 12 months, Medacta Group has paid 19.10 million in taxes.
| Income Tax | 19.10M |
| Effective Tax Rate | 21.11% |
Stock Price Statistics
The stock price has decreased by -20.59% in the last 52 weeks. The beta is 1.01, so Medacta Group's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -20.59% |
| 50-Day Moving Average | 124.04 |
| 200-Day Moving Average | 142.89 |
| Relative Strength Index (RSI) | 38.20 |
| Average Volume (20 Days) | 38,761 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medacta Group had revenue of CHF 653.43 million and earned 71.34 million in profits. Earnings per share was 3.57.
| Revenue | 653.43M |
| Gross Profit | 428.05M |
| Operating Income | 99.22M |
| Pretax Income | 90.44M |
| Net Income | 71.34M |
| EBITDA | 157.41M |
| EBIT | 99.22M |
| Earnings Per Share (EPS) | 3.57 |
Balance Sheet
The company has 33.22 million in cash and 295.94 million in debt, with a net cash position of -262.71 million or -13.17 per share.
| Cash & Cash Equivalents | 33.22M |
| Total Debt | 295.94M |
| Net Cash | -262.71M |
| Net Cash Per Share | -13.17 |
| Equity (Book Value) | 445.99M |
| Book Value Per Share | 22.36 |
| Working Capital | 240.19M |
Cash Flow
In the last 12 months, operating cash flow was 124.99 million and capital expenditures -126.62 million, giving a free cash flow of -1.63 million.
| Operating Cash Flow | 124.99M |
| Capital Expenditures | -126.62M |
| Depreciation & Amortization | 58.78M |
| Net Borrowing | 38.30M |
| Free Cash Flow | -1.63M |
| FCF Per Share | -0.08 |
Margins
Gross margin is 65.51%, with operating and profit margins of 15.18% and 10.92%.
| Gross Margin | 65.51% |
| Operating Margin | 15.18% |
| Pretax Margin | 13.84% |
| Profit Margin | 10.92% |
| EBITDA Margin | 24.09% |
| EBIT Margin | 15.18% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.97%.
| Dividend Per Share | 1.10 |
| Dividend Yield | 0.97% |
| Dividend Growth (YoY) | 59.42% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 31.05% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | 0.91% |
| Earnings Yield | 3.15% |
| FCF Yield | -0.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Medacta Group is 162.83, which is 43.59% higher than the current price. The consensus rating is "Buy".
| Price Target | 162.83 |
| Price Target Difference | 43.59% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 12.00% |
| EPS Growth Forecast (3Y) | 15.52% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medacta Group has an Altman Z-Score of 5.67 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.67 |
| Piotroski F-Score | 4 |